Skip to main content

News

Press Release
11/12/2013
ChanRx, a firm developing medicines for cardiovascular diseases, announced that it will be presenting the results of its Phase IIb study of vanoxerine (GBR-12909), a drug under study for the treatment of atrial fibrillation, at the American...
ChanRx, a firm developing medicines for cardiovascular diseases, announced that it will be presenting the results of its Phase IIb study of vanoxerine (GBR-12909), a drug under study for the treatment of atrial fibrillation, at the American...
ChanRx, a firm developing...
11/12/2013
EP Lab Digest
Press Release
11/12/2013
DALLAS, Nov. 11, 2013 — A promising technology may enable doctors to diagnose and possibly treat in utero a common cause of stillbirth and sudden death in infants, according to research published in the American Heart Association journal...
DALLAS, Nov. 11, 2013 — A promising technology may enable doctors to diagnose and possibly treat in utero a common cause of stillbirth and sudden death in infants, according to research published in the American Heart Association journal...
DALLAS, Nov. 11, 2013 — A...
11/12/2013
EP Lab Digest
Press Release
11/12/2013
CardioInsight Technologies, Inc., a leading developer of non-invasive electrocardiographic mapping technology, announced that it has completed a long-term strategic financing that provides the Company with an initial investment of $15...
CardioInsight Technologies, Inc., a leading developer of non-invasive electrocardiographic mapping technology, announced that it has completed a long-term strategic financing that provides the Company with an initial investment of $15...
CardioInsight Technologies,...
11/12/2013
EP Lab Digest
Press Release
11/08/2013
Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, announced that it has received 510(k) clearance by the U.S. Food...
Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, announced that it has received 510(k) clearance by the U.S. Food...
Topera, Inc., a medical device...
11/08/2013
EP Lab Digest
Press Release
11/07/2013
LIA Software Proven to Detect Lead Failures More Frequently than Impedance Alone on Riata, Durata and Endotak Leads Medtronic, Inc. announced FDA approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic leads....
LIA Software Proven to Detect Lead Failures More Frequently than Impedance Alone on Riata, Durata and Endotak Leads Medtronic, Inc. announced FDA approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic leads....
LIA Software Proven to Detect...
11/07/2013
EP Lab Digest
Press Release
11/07/2013
HeartSine Technologies is pleased to announce the arrival of its enhanced samaritan® Public Access Defibrillator (PAD) Trainer, which offers new features that simplify CPR and AED training. The new samaritan PAD Trainer with remote control...
HeartSine Technologies is pleased to announce the arrival of its enhanced samaritan® Public Access Defibrillator (PAD) Trainer, which offers new features that simplify CPR and AED training. The new samaritan PAD Trainer with remote control...
HeartSine Technologies is...
11/07/2013
EP Lab Digest
Press Release
11/07/2013
ZipLine Medical announced that Kaiser Permanente Santa Clara Medical Center has adopted its patented noninvasive Zip™ surgical skin-closure devices for cardiac implant surgery. This is in addition to ZipLine’s adoption by hospitals throughout...
ZipLine Medical announced that Kaiser Permanente Santa Clara Medical Center has adopted its patented noninvasive Zip™ surgical skin-closure devices for cardiac implant surgery. This is in addition to ZipLine’s adoption by hospitals throughout...
ZipLine Medical announced that...
11/07/2013
EP Lab Digest
Press Release
11/07/2013
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, and Duke University’s Duke Clinical Research Institute (DCRI), the world’s largest academic clinical research...
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, and Duke University’s Duke Clinical Research Institute (DCRI), the world’s largest academic clinical research...
ARCA biopharma, Inc., a...
11/07/2013
EP Lab Digest
Press Release
11/07/2013
Unfors RaySafe (formerly Unfors Instruments), the leading international supplier of measurement solutions for quality assurance of X-ray equipment, has launched its new RaySafe X2 Prestige System consisting of a base unit and external sensors...
Unfors RaySafe (formerly Unfors Instruments), the leading international supplier of measurement solutions for quality assurance of X-ray equipment, has launched its new RaySafe X2 Prestige System consisting of a base unit and external sensors...
Unfors RaySafe (formerly Unfors...
11/07/2013
EP Lab Digest
Press Release
11/04/2013
The first-ever Cardiovascular Health Week kicks off in the European Parliament in Brussels. It will go on until 8 November 2013 with awareness-raising activities around the theme ‘Mind Your Heart – for a Heart Healthy Europe’. The initiative...
The first-ever Cardiovascular Health Week kicks off in the European Parliament in Brussels. It will go on until 8 November 2013 with awareness-raising activities around the theme ‘Mind Your Heart – for a Heart Healthy Europe’. The initiative...
The first-ever Cardiovascular...
11/04/2013
EP Lab Digest